Long Island City, NY, United States of America

Ritu Rohit Kaushik

This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ritu Rohit Kaushik. Retrieved from https://idiyas.com/inventor/ritu-rohit-kaushik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 189(Granted Patents)

Location History:

Watertown, MA (US) (2013)
Longisland City, NY (US) (2016 - 2021)

Company Filing History:

4 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2013-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11052075 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2021-07-06),

2. 10076513 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2018-09-18),

3. 9241934 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2016-01-26),

4. 8552034 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2013-10-08),

Title: Ritu Rohit Kaushik: Innovator in Pharmaceutical Research

Introduction

Ritu Rohit Kaushik is an accomplished inventor based in Long Island City, NY, with a notable portfolio comprising four patents. His contributions primarily focus on advancements in pharmaceutical compositions, particularly those aimed at treating serious medical conditions. Kaushik's innovative work demonstrates a commitment to improving patient care through targeted therapies.

Latest Patents

Ritu Rohit Kaushik's latest patents revolve around pharmaceutical compositions that include 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid. These compositions are designed for oral administration to patients suffering from CFTR mediated diseases, such as Cystic Fibrosis. Each patent emphasizes the formulation of the compound alongside various excipients, which enhance the efficacy and delivery of the medication to those in need.

Career Highlights

Kaushik is currently employed at Vertex Pharmaceuticals, Inc., where he has taken significant strides in the pharmaceutical development sector. His work is instrumental in advancing new therapeutic options for patients, reflecting his passion for innovation and dedication to enhancing healthcare outcomes.

Collaborations

Throughout his professional journey, Ritu Rohit Kaushik has collaborated with esteemed colleagues, including Marinus Jacobus Verwijs and Rossitza Gueorguieva Alargova. These partnerships highlight the collaborative efforts in research and development, contributing to the success of their innovative pharmaceutical projects.

Conclusion

Ritu Rohit Kaushik stands out as a prominent inventor within the pharmaceutical field, with multiple patents that promise to impact treatment options for patients with complex diseases. His work at Vertex Pharmaceuticals, Inc. and collaborations with talented individuals underscores the vital role of innovative thinkers in advancing medical science.

Profile summary based on public USPTO records.